Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

COO vs BLCO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
COO
The Cooper Companies, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$11.97B
5Y Perf.-30.3%
BLCO
Bausch + Lomb Corporation

Medical - Instruments & Supplies

HealthcareNYSE • CA
Market Cap$5.70B
5Y Perf.-5.9%

COO vs BLCO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
COO logoCOO
BLCO logoBLCO
IndustryMedical - Instruments & SuppliesMedical - Instruments & Supplies
Market Cap$11.97B$5.70B
Revenue (TTM)$4.15B$5.21B
Net Income (TTM)$401M$-219M
Gross Margin64.2%55.9%
Operating Margin17.2%5.9%
Forward P/E13.2x20.2x
Total Debt$2.78B$5.37B
Cash & Equiv.$111M$383M

COO vs BLCOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

COO
BLCO
StockMay 22May 26Return
The Cooper Companie… (COO)10069.7-30.3%
Bausch + Lomb Corpo… (BLCO)10094.1-5.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: COO vs BLCO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: COO leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Bausch + Lomb Corporation is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
COO
The Cooper Companies, Inc.
The Income Pick

COO carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 0 yrs, beta 0.93
  • 59.8% 10Y total return vs BLCO's -20.0%
  • Lower volatility, beta 0.93, Low D/E 33.8%, current ratio 1.89x
Best for: income & stability and long-term compounding
BLCO
Bausch + Lomb Corporation
The Growth Play

BLCO is the clearest fit if your priority is growth exposure.

  • Rev growth 6.5%, EPS growth -13.3%, 3Y rev CAGR 10.6%
  • 6.5% revenue growth vs COO's 5.1%
  • +46.8% vs COO's -24.1%
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthBLCO logoBLCO6.5% revenue growth vs COO's 5.1%
ValueCOO logoCOOLower P/E (13.2x vs 20.2x)
Quality / MarginsCOO logoCOO9.7% margin vs BLCO's -4.2%
Stability / SafetyCOO logoCOOBeta 0.93 vs BLCO's 1.39, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)BLCO logoBLCO+46.8% vs COO's -24.1%
Efficiency (ROA)COO logoCOO3.2% ROA vs BLCO's -1.6%, ROIC 4.8% vs 1.2%

COO vs BLCO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

COOThe Cooper Companies, Inc.
FY 2025
Coopervision Segment
67.0%$2.7B
Coopersurgical Segment
33.0%$1.3B
BLCOBausch + Lomb Corporation
FY 2025
Device Products
37.7%$1.9B
Over the Counter Products
36.0%$1.8B
Pharmaceutical Products
21.2%$1.1B
Branded and Other Generic Products
4.8%$243M
Other Revenues
0.4%$21M

COO vs BLCO — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCOOLAGGINGBLCO

Income & Cash Flow (Last 12 Months)

COO leads this category, winning 4 of 6 comparable metrics.

BLCO and COO operate at a comparable scale, with $5.2B and $4.2B in trailing revenue. COO is the more profitable business, keeping 9.7% of every revenue dollar as net income compared to BLCO's -4.2%. On growth, BLCO holds the edge at +9.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCOO logoCOOThe Cooper Compan…BLCO logoBLCOBausch + Lomb Cor…
RevenueTrailing 12 months$4.2B$5.2B
EBITDAEarnings before interest/tax$1.0B$724M
Net IncomeAfter-tax profit$401M-$219M
Free Cash FlowCash after capex$333M$4M
Gross MarginGross profit ÷ Revenue+64.2%+55.9%
Operating MarginEBIT ÷ Revenue+17.2%+5.9%
Net MarginNet income ÷ Revenue+9.7%-4.2%
FCF MarginFCF ÷ Revenue+8.0%+0.1%
Rev. Growth (YoY)Latest quarter vs prior year+6.2%+9.4%
EPS Growth (YoY)Latest quarter vs prior year+26.9%+66.7%
COO leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

BLCO leads this category, winning 3 of 5 comparable metrics.

On an enterprise value basis, COO's 13.2x EV/EBITDA is more attractive than BLCO's 17.6x.

MetricCOO logoCOOThe Cooper Compan…BLCO logoBLCOBausch + Lomb Cor…
Market CapShares × price$12.0B$5.7B
Enterprise ValueMkt cap + debt − cash$14.6B$10.7B
Trailing P/EPrice ÷ TTM EPS32.68x-15.69x
Forward P/EPrice ÷ next-FY EPS est.13.24x20.23x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple13.24x17.56x
Price / SalesMarket cap ÷ Revenue2.93x1.12x
Price / BookPrice ÷ Book value/share1.48x0.87x
Price / FCFMarket cap ÷ FCF27.61x
BLCO leads this category, winning 3 of 5 comparable metrics.

Profitability & Efficiency

COO leads this category, winning 9 of 9 comparable metrics.

COO delivers a 4.8% return on equity — every $100 of shareholder capital generates $5 in annual profit, vs $-3 for BLCO. COO carries lower financial leverage with a 0.34x debt-to-equity ratio, signaling a more conservative balance sheet compared to BLCO's 0.82x. On the Piotroski fundamental quality scale (0–9), COO scores 5/9 vs BLCO's 3/9, reflecting solid financial health.

MetricCOO logoCOOThe Cooper Compan…BLCO logoBLCOBausch + Lomb Cor…
ROE (TTM)Return on equity+4.8%-3.4%
ROA (TTM)Return on assets+3.2%-1.6%
ROICReturn on invested capital+4.8%+1.2%
ROCEReturn on capital employed+6.1%+1.6%
Piotroski ScoreFundamental quality 0–953
Debt / EquityFinancial leverage0.34x0.82x
Net DebtTotal debt minus cash$2.7B$5.0B
Cash & Equiv.Liquid assets$111M$383M
Total DebtShort + long-term debt$2.8B$5.4B
Interest CoverageEBIT ÷ Interest expense6.40x0.71x
COO leads this category, winning 9 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

BLCO leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in BLCO five years ago would be worth $8,000 today (with dividends reinvested), compared to $6,033 for COO. Over the past 12 months, BLCO leads with a +46.8% total return vs COO's -24.1%. The 3-year compound annual growth rate (CAGR) favors BLCO at -4.3% vs COO's -14.1% — a key indicator of consistent wealth creation.

MetricCOO logoCOOThe Cooper Compan…BLCO logoBLCOBausch + Lomb Cor…
YTD ReturnYear-to-date-24.6%-3.5%
1-Year ReturnPast 12 months-24.1%+46.8%
3-Year ReturnCumulative with dividends-36.7%-12.5%
5-Year ReturnCumulative with dividends-39.7%-20.0%
10-Year ReturnCumulative with dividends+59.8%-20.0%
CAGR (3Y)Annualised 3-year return-14.1%-4.3%
BLCO leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — COO and BLCO each lead in 1 of 2 comparable metrics.

COO is the less volatile stock with a 0.93 beta — it tends to amplify market swings less than BLCO's 1.39 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BLCO currently trades 84.6% from its 52-week high vs COO's 68.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCOO logoCOOThe Cooper Compan…BLCO logoBLCOBausch + Lomb Cor…
Beta (5Y)Sensitivity to S&P 5000.93x1.39x
52-Week HighHighest price in past year$89.83$18.92
52-Week LowLowest price in past year$60.00$10.83
% of 52W HighCurrent price vs 52-week peak+68.0%+84.6%
RSI (14)Momentum oscillator 0–10025.046.9
Avg Volume (50D)Average daily shares traded2.0M416K
Evenly matched — COO and BLCO each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates COO as "Buy" and BLCO as "Hold". Consensus price targets imply 53.6% upside for COO (target: $94) vs 18.8% for BLCO (target: $19).

MetricCOO logoCOOThe Cooper Compan…BLCO logoBLCOBausch + Lomb Cor…
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$93.86$19.00
# AnalystsCovering analysts2416
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+2.4%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

COO leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BLCO leads in 2 (Valuation Metrics, Total Returns). 1 tied.

Best OverallThe Cooper Companies, Inc. (COO)Leads 2 of 6 categories
Loading custom metrics...

COO vs BLCO: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is COO or BLCO a better buy right now?

For growth investors, Bausch + Lomb Corporation (BLCO) is the stronger pick with 6.

5% revenue growth year-over-year, versus 5. 1% for The Cooper Companies, Inc. (COO). The Cooper Companies, Inc. (COO) offers the better valuation at 32. 7x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate The Cooper Companies, Inc. (COO) a "Buy" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — COO or BLCO?

On forward P/E, The Cooper Companies, Inc.

is actually cheaper at 13. 2x.

03

Which is the better long-term investment — COO or BLCO?

Over the past 5 years, Bausch + Lomb Corporation (BLCO) delivered a total return of -20.

0%, compared to -39. 7% for The Cooper Companies, Inc. (COO). Over 10 years, the gap is even starker: COO returned +59. 8% versus BLCO's -20. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — COO or BLCO?

By beta (market sensitivity over 5 years), The Cooper Companies, Inc.

(COO) is the lower-risk stock at 0. 93β versus Bausch + Lomb Corporation's 1. 39β — meaning BLCO is approximately 50% more volatile than COO relative to the S&P 500. On balance sheet safety, The Cooper Companies, Inc. (COO) carries a lower debt/equity ratio of 34% versus 82% for Bausch + Lomb Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — COO or BLCO?

By revenue growth (latest reported year), Bausch + Lomb Corporation (BLCO) is pulling ahead at 6.

5% versus 5. 1% for The Cooper Companies, Inc. (COO). On earnings-per-share growth, the picture is similar: The Cooper Companies, Inc. grew EPS -4. 6% year-over-year, compared to -13. 3% for Bausch + Lomb Corporation. Over a 3-year CAGR, BLCO leads at 10. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — COO or BLCO?

The Cooper Companies, Inc.

(COO) is the more profitable company, earning 9. 2% net margin versus -7. 1% for Bausch + Lomb Corporation — meaning it keeps 9. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: COO leads at 16. 7% versus 3. 7% for BLCO. At the gross margin level — before operating expenses — COO leads at 60. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is COO or BLCO more undervalued right now?

On forward earnings alone, The Cooper Companies, Inc.

(COO) trades at 13. 2x forward P/E versus 20. 2x for Bausch + Lomb Corporation — 7. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for COO: 53. 6% to $93. 86.

08

Which pays a better dividend — COO or BLCO?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is COO or BLCO better for a retirement portfolio?

For long-horizon retirement investors, The Cooper Companies, Inc.

(COO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 93)). Both have compounded well over 10 years (COO: +59. 8%, BLCO: -20. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between COO and BLCO?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

COO

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

BLCO

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 33%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform COO and BLCO on the metrics below

Revenue Growth>
%
(COO: 6.2% · BLCO: 9.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.